Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1.

De Luca A, Parker LJ, Ang WH, Rodolfo C, Gabbarini V, Hancock NC, Palone F, Mazzetti AP, Menin L, Morton CJ, Parker MW, Lo Bello M, Dyson PJ.

Proc Natl Acad Sci U S A. 2019 Jun 20. pii: 201903297. doi: 10.1073/pnas.1903297116. [Epub ahead of print]

2.

Distinct Mechanisms of Pathogenic DJ-1 Mutations in Mitochondrial Quality Control.

Strobbe D, Robinson AA, Harvey K, Rossi L, Ferraina C, de Biase V, Rodolfo C, Harvey RJ, Campanella M.

Front Mol Neurosci. 2018 Mar 15;11:68. doi: 10.3389/fnmol.2018.00068. eCollection 2018.

3.

Mitophagy in neurodegenerative diseases.

Rodolfo C, Campello S, Cecconi F.

Neurochem Int. 2018 Jul;117:156-166. doi: 10.1016/j.neuint.2017.08.004. Epub 2017 Aug 8. Review.

PMID:
28797885
4.

Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance.

Poerio N, Bugli F, Taus F, Santucci MB, Rodolfo C, Cecconi F, Torelli R, Varone F, Inchingolo R, Majo F, Lucidi V, Mariotti S, Nisini R, Sanguinetti M, Fraziano M.

Sci Rep. 2017 Mar 27;7:45120. doi: 10.1038/srep45120.

5.

Ophiobolin A Induces Autophagy and Activates the Mitochondrial Pathway of Apoptosis in Human Melanoma Cells.

Rodolfo C, Rocco M, Cattaneo L, Tartaglia M, Sassi M, Aducci P, Scaloni A, Camoni L, Marra M.

PLoS One. 2016 Dec 9;11(12):e0167672. doi: 10.1371/journal.pone.0167672. eCollection 2016.

6.

Fine-tuning of ULK1 mRNA and protein levels is required for autophagy oscillation.

Nazio F, Carinci M, Valacca C, Bielli P, Strappazzon F, Antonioli M, Ciccosanti F, Rodolfo C, Campello S, Fimia GM, Sette C, Bonaldo P, Cecconi F.

J Cell Biol. 2016 Dec 19;215(6):841-856. Epub 2016 Dec 8.

7.

Autophagy in stem and progenitor cells.

Rodolfo C, Di Bartolomeo S, Cecconi F.

Cell Mol Life Sci. 2016 Feb;73(3):475-96. doi: 10.1007/s00018-015-2071-3. Epub 2015 Oct 26. Review.

PMID:
26502349
8.

Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states.

Piacentini M, D'Eletto M, Farrace MG, Rodolfo C, Del Nonno F, Ippolito G, Falasca L.

Cell Tissue Res. 2014 Dec;358(3):793-805. doi: 10.1007/s00441-014-1990-x. Epub 2014 Sep 11.

9.

Transglutaminase 2 at the crossroads between cell death and survival.

Piacentini M, D'Eletto M, Falasca L, Farrace MG, Rodolfo C.

Adv Enzymol Relat Areas Mol Biol. 2011;78:197-246. Review. No abstract available.

PMID:
22220475
10.

Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase.

Nicoll WS, Sacci JB, Rodolfo C, Di Giacomo G, Piacentini M, Holland ZJ, Doerig C, Hollingdale MR, Lanar DE.

Malar J. 2011 Jan 21;10:14. doi: 10.1186/1475-2875-10-14.

11.

Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases.

Rodolfo C, Ciccosanti F, Giacomo GD, Piacentini M, Fimia GM.

Expert Rev Proteomics. 2010 Aug;7(4):519-42. doi: 10.1586/epr.10.43. Review.

PMID:
20653508
12.

The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis.

Malorni W, Farrace MG, Matarrese P, Tinari A, Ciarlo L, Mousavi-Shafaei P, D'Eletto M, Di Giacomo G, Melino G, Palmieri L, Rodolfo C, Piacentini M.

Cell Death Differ. 2009 Nov;16(11):1480-92. doi: 10.1038/cdd.2009.100. Epub 2009 Jul 31.

13.

More than two sides of a coin? How to detect the multiple activities of type 2 transglutaminase.

Rodolfo C, Falasca L, Di Giacomo G, Mastroberardino PG, Piacentini M.

Methods Enzymol. 2008;442:201-12. doi: 10.1016/S0076-6879(08)01410-9.

PMID:
18662571
14.

In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma.

Di Giacomo G, Lentini A, Beninati S, Piacentini M, Rodolfo C.

Amino Acids. 2009 Apr;36(4):717-24. doi: 10.1007/s00726-008-0119-5. Epub 2008 Jul 2.

PMID:
18594948
15.

Type 2 transglutaminase in neurodegenerative diseases: the mitochondrial connection.

Malorni W, Farrace MG, Rodolfo C, Piacentini M.

Curr Pharm Des. 2008;14(3):278-88. Review.

PMID:
18220838
16.

"Tissue" transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes.

Mastroberardino PG, Farrace MG, Viti I, Pavone F, Fimia GM, Melino G, Rodolfo C, Piacentini M.

Biochim Biophys Acta. 2006 Sep-Oct;1757(9-10):1357-65. Epub 2006 Aug 3.

17.

Type 2 transglutaminase and cell death.

Piacentini M, Amendola A, Ciccosanti F, Falasca L, Farrace MG, Mastroberardino PG, Nardacci R, Oliverio S, Piredda L, Rodolfo C, Autuori F.

Prog Exp Tumor Res. 2005;38:58-74. Review. No abstract available.

PMID:
15746529
18.

Tissue transglutaminase is a multifunctional BH3-only protein.

Rodolfo C, Mormone E, Matarrese P, Ciccosanti F, Farrace MG, Garofano E, Piredda L, Fimia GM, Malorni W, Piacentini M.

J Biol Chem. 2004 Dec 24;279(52):54783-92. Epub 2004 Oct 12.

19.

Bak: a downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cells.

Lovat PE, Oliverio S, Corazzari M, Rodolfo C, Ranalli M, Goranov B, Melino G, Redfern CP, Piacentini M.

Cancer Res. 2003 Nov 1;63(21):7310-3.

20.

GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.

Lovat PE, Oliverio S, Ranalli M, Corazzari M, Rodolfo C, Bernassola F, Aughton K, Maccarrone M, Hewson QD, Pearson AD, Melino G, Piacentini M, Redfern CP.

Cancer Res. 2002 Sep 15;62(18):5158-67.

21.

Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress.

Piacentini M, Farrace MG, Piredda L, Matarrese P, Ciccosanti F, Falasca L, Rodolfo C, Giammarioli AM, Verderio E, Griffin M, Malorni W.

J Neurochem. 2002 Jun;81(5):1061-72.

22.

Does cytoskeleton 'Akt' in apoptosis?

Rodolfo C, Piacentini M.

Cell Death Differ. 2002 May;9(5):477-8. No abstract available.

23.

"Tissue" transglutaminase expression in HIV-infected cells: an enzyme with an antiviral effect?

Amendola A, Rodolfo C, Di Caro A, Ciccosanti F, Falasca L, Piacentini M.

Ann N Y Acad Sci. 2001 Nov;946:108-20. Review.

PMID:
11762979
24.

"Tissue" transglutaminase in animal development.

Piacentini M, Rodolfo C, Farrace MG, Autuori F.

Int J Dev Biol. 2000;44(6):655-62. Review.

25.

Inhibition of "tissue" transglutaminase increases cell survival by preventing apoptosis.

Oliverio S, Amendola A, Rodolfo C, Spinedi A, Piacentini M.

J Biol Chem. 1999 Nov 26;274(48):34123-8.

26.

Ceramide accumulation precedes caspase-dependent apoptosis in CHP-100 neuroepithelioma cells exposed to the protein phosphatase inhibitor okadaic acid.

Spinedi A, Di Bartolomeo S, Di Sano F, Rodolfo C, Ambrosino A, Piacentini M.

Cell Death Differ. 1999 Jul;6(7):618-23.

27.

Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH.

Coin F, Marinoni JC, Rodolfo C, Fribourg S, Pedrini AM, Egly JM.

Nat Genet. 1998 Oct;20(2):184-8.

PMID:
9771713
28.

Human DNA topoisomerase I-mediated cleavages stimulated by ultraviolet light-induced DNA damage.

Lanza A, Tornaletti S, Rodolfo C, Scanavini MC, Pedrini AM.

J Biol Chem. 1996 Mar 22;271(12):6978-86.

29.

The ultimate carcinogen of 4-nitroquinoline 1-oxide does not react with Z-DNA and hyperreacts with B-Z junctions.

Rodolfo C, Lanza A, Tornaletti S, Fronza G, Pedrini AM.

Nucleic Acids Res. 1994 Feb 11;22(3):314-20.

Supplemental Content

Loading ...
Support Center